[1] ZELBER-SAGI S, RATZIU V, OREN R. Nutrition and physical activity in NAFLD:An overview of the epidemiological evidence[J]. World Gastroenterol, 2011, 17 (29) :3377-3389.
|
[2] FABBRINI E, SULLIVAN S, KLEIN S. Obesity and nonalcoholic fatty liver disease:Biochemical, metabolic, and clinical implications[J]. Hepatology, 2010, 51:679-689.
|
[3] MARGARITI E, DEUTSCH M, MANOLAKOPOULOS S, et al.Nonalcoholic fatty liver disease may develop in individuals with normal body mass index[J]. Ann Gastroenterol, 2012, 25 (1) :45-51.
|
[4] HUANG ZP, SU ZJ, JIANG JJ, et al. The analysis of the relationship between the extence of non-alcoholic fatty liver disease and metabolic syndrome’s components[J]. Clin Med China, 2013, 29 (11) :1158-1161. (in Chinese) 黄志鹏, 苏智军, 蒋建家, 等.非酒精性脂肪肝严重程度与代谢综合征组分的相关性分析[J].中国综合临床, 2013, 29 (11) :1158-1161.
|
[5] ZHAO ZG. Relationship between C-reactive protein and visceral fat obesity and their impacts on target organ damage[D]. Chongqing:The Third Military Medical University, 2009. (in Chinese) 赵志钢. C反应蛋白与内脏脂肪型肥胖及其相关靶器官损害的关系[D].重庆:第三军医大学, 2009.
|
[6] The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association.Guidelines for management of nonalcoholic fatty liver diseas[J]. J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.
|
[7] Department of Disease Control, Ministry of Health of the People’s Republic of China. Guide-lines for prevention and control of overweight and obesity in Chinese adults (Excerpt) [J]. Acta Nutrimenta Sinica, 2004, 26 (1) :1-4. (in Chinese) 中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防与控制指南 (节录) [J].营养学报, 2004, 26 (1) :1-4.
|
[8] CHUNG GE, KIM D, KWARK MS, et al. Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease[J]. Medicine, 2015, 94 (9) :1-8.
|
[9] KIM D, KIM WR. Nonobese fatty liver disease[J]. Clin Gastroenterol Hepatol, 2017, 15 (4) :474-485.
|
[10] GONZALEZ-CANTERO J, MARTIN-RODRIGUEZ JL, GONZALEZ-CANTERO A, et al. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese his-panic patients:A pilot study[J]. Lipids Health Dis, 2017, 16 (1) :129.
|
[11] BUGIANESI E, ZANNONI C, VANNI E, et al. Non-alcoholic fatty liver and insulin resistance:A cause-effect relationship?[J]. Dig Liver Dis, 2004, 36 (3) :165-173.
|
[12] BHAT G, BABA CS, PANDEY A, et al. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease[J]. World J Hepatol, 2012, 4 (7) :209-217.
|
[13] LI C, GUO P, OKEKUNLE AP, et al. Lean non-alcoholic fatty liver disease patients had compareable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver diseasepatients[J]. J Gastroenterol Hepatol, 2018.[Epub ahead of print]
|
[14] DAS K, DAS K, MUKHERJEE PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease[J]. Hepatology, 2010, 51:1593-1602.
|
[15] KUMAR R, MOHAN S. Non-alcoholic fatty liver disease in lean subjects:Characteristics and Implications[J]. J Clin Transl Hepatol, 2017, 5 (3) :216-223.
|
[16] BHAT G, BABA CS, PANDEY A, et al. Insulin resistance and metabolic syndrome in non-obese Indian patients with nonalcoholic fatty liver disease[J]. Trop Gastroenterol, 2013, 34 (1) :18-24.
|
[17] GONZALEZ-CANTERO J, MARTIN-RODRIGUEZ JL, GONZALEZ-CANTERO A, et al. Insulin resistance in lean and overweight non-diabetic Caucasian adults:Study of its relationship with liver triglyceride content, waist circumference and BMI[J]. PLo S One, 2018, 13 (2) :1-13.
|
[18] FRACANZANI AL, VALENTI L, BUGIANESI E, et al. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity[J]. J Hepatol, 2011, 54:1244-1249.
|
[19] SOOKOIAN S, PIROLA CJ. Systematic review with meta-analysis:Risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile betweenn lean and obese patients[J]. Aliment Pharmacol Ther, 2017, 46 (2) :85-95.
|
[20] LENG XJ, YAN XB. Efficiency of FibroTouch in evaluating liver fibrosis degree in nonalcoholic fatty liver disease patients with different levels of body mass index[J]. J Clin Hepatol, 2018, 34 (9) :1891-1895. (in Chinese) 冷雪君, 颜学兵. FibroTouch对不同BMI水平非酒精性脂肪性肝病患者肝纤维化程度的评估比较[J].临床肝胆病杂志, 2018, 34 (9) :1891-1895.
|